IRIS Accounts Production v26.1.0.640 12095777 director 1.4.25 31.3.26 31.3.26 0 0 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh120957772025-03-31120957772026-03-31120957772025-04-012026-03-31120957772024-03-31120957772024-04-012025-03-31120957772025-03-3112095777ns15:EnglandWales2025-04-012026-03-3112095777ns14:PoundSterling2025-04-012026-03-3112095777ns10:Director12025-04-012026-03-3112095777ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3112095777ns10:Micro-entities2025-04-012026-03-3112095777ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-3112095777ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3112095777ns10:FullAccounts2025-04-012026-03-3112095777ns5:CurrentFinancialInstruments2026-03-3112095777ns5:CurrentFinancialInstruments2025-03-3112095777ns10:RegisteredOffice2025-04-012026-03-31
REGISTERED NUMBER: 12095777 (England and Wales)



















Unaudited Financial Statements

for the Year Ended 31 March 2026

for

NP ONCOLOGY LTD

NP ONCOLOGY LTD (REGISTERED NUMBER: 12095777)

Contents of the Financial Statements
for the Year Ended 31 March 2026










Page

Balance Sheet 1


NP ONCOLOGY LTD (REGISTERED NUMBER: 12095777)

Balance Sheet
31 March 2026

2026 2025
£ £
FIXED ASSETS 1,091 55

CURRENT ASSETS 414,199 299,835

CREDITORS
Amounts falling due within one year (77,543 ) (51,019 )
NET CURRENT ASSETS 336,656 248,816
TOTAL ASSETS LESS CURRENT
LIABILITIES

337,747

248,871

CAPITAL AND RESERVES 337,747 248,871

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

NP Oncology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 12095777

Registered office: 2 St Mary's Road
Tonbridge
Kent
TN9 2LB

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was NIL (2025 - NIL).



NP ONCOLOGY LTD (REGISTERED NUMBER: 12095777)

Balance Sheet - continued
31 March 2026


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 12 May 2026 and were signed by:





Dr N Patel - Director